Syed F. Ali

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

High Impact

Role not yet determined Is this you? Add your title

NCTR primary UA Little Rock UAMS

Also affiliated: Bluefield State College (2022); Meharry Medical College (1998–2007); Cedars-Sinai Medical Center (2022); Brigham and Women's Hospital (2013–2015); MedStar Washington Hospital Center (2022); United States Department of Health and Human Services (2016); National Institutes of Health (1998); Environmental Protection Agency (1998); Beth Israel Deaconess Medical Center (2014); United States Food and Drug Administration (1989–2022); Westchester Medical Center (2023–2024); National Institute on Drug Abuse (1998); St. George's University (2018); Harvard University (1998–2018); University of Kentucky (2014); University of Miami (1998); FMC (United States) (1992–2007); Madurai Medical College (2022); Jinan University (2012); University of California, Los Angeles (2013–2015); University of Calgary (2013–2015); Duke University (2015); Iowa State University (2006); New York Medical College (2023); Dalian Medical University (2004); University of Saint Joseph (2024); National Institute for Occupational Safety and Health (1998); Princeton University (1995); University of California, Irvine (1995); University of Utah (2018); Augusta University (2018); University of Arkansas Medical Center (2014); Ronald Reagan UCLA Medical Center (2015); VA Boston Healthcare System (2013); Centre Hospitalier Universitaire Vaudois (2014); University of California San Diego (2004–2020); Massachusetts General Hospital (1998–2018); National Institute of Environmental Health Sciences (1983–1984); Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques (2011); Chevron (United States) (1996–1998); München Klinik (2018); Pitié-Salpêtrière Hospital (2014); Duke Medical Center (2013–2014); Kokilaben Dhirubhai Ambani Hospital (2014); Instituto Nacional de Neurología y Neurocirugía (2001); National Institute for Research and Development of Isotopic and Molecular Technologies (2010); Phoenixville Hospital (2022); National Research Council Canada (1986); Royal Devon University Healthcare NHS Foundation Trust (2025); Hotchkiss Brain Institute (2013–2015); Université Pierre-et-Marie-Curie (2014); University of Regensburg (2018); Drexel University (2022); University of Pennsylvania (2013); Florida Agricultural and Mechanical University (1997); Michigan State University (2013–2015); Texas A&M University (1995)

76 h-index 556 pubs 20,903 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website

OverviewAI-generated summary

Syed F. Ali's research centers on neurotoxicology and the effects of various substances and materials on the nervous system. He has investigated the impact of nanomaterials, such as silver and manganese nanoparticles, on neural cells, examining mechanisms like dopamine depletion and blood-brain barrier inflammation. His work also includes studying the neurotoxic effects of drugs, including methamphetamine, and factors influencing these effects, such as environmental temperature and gender.

His research has explored gene expression related to oxidative stress in the brain following exposure to nanoparticles. Additionally, Ali has contributed to studies on acute ischemic stroke, analyzing patient characteristics and treatment trends. His scholarship metrics include an h-index of 76, with 587 publications and over 21,000 citations, designating him as a highly cited researcher. He has collaborated with researchers at the University of Arkansas at Fayetteville, including Kartik Balachandran, Jeffrey C. Wolchok, Celeste Dunn, and Sara M. Venier.

Metrics

h-index: 76
Publications: 556
Citations: 20,903

Selected Publications

Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296] (2025)

DOI OpenAlex
Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78] (2024)

DOI OpenAlex
The Endocannabinoid System in the Central Nervous System: Emphasis on the Role of the Mitochondrial Cannabinoid Receptor 1 (mtCB1R) (2022)

DOI OpenAlex
Functional Analysis of the Cortical Transcriptome and Proteome Reveal Neurogenesis, Inflammation, and Cell Death after Repeated Traumatic Brain Injury <i>In vivo</i> (2022)

4 citations DOI OpenAlex
Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model (2022)

2 citations DOI OpenAlex
Blood–Brain Barrier Breakdown and Astrocyte Reactivity Evident in the Absence of Behavioral Changes after Repeated Traumatic Brain Injury (2021)

21 citations DOI OpenAlex
The Endocannabinoid System in the Central Nervous System: Emphasis on the Role of the Mitochondrial Cannabinoid Receptor 1 (mtCB1R) (2021)

5 citations DOI OpenAlex
Acute MDPV Binge Paradigm on Mice Emotional Behavior and Glial Signature (2021)

4 citations DOI OpenAlex
Neurotoxicity of thallium: Old issues and new developments (2021)

1 citation DOI OpenAlex
Amyloid Beta 25–35 induces blood-brain barrier disruption in vitro (2019)

Metabolic Brain Disease 57 citations DOI OpenAlex
Iron oxide nanoparticles induce cytokine secretion in a complement-dependent manner in a human whole blood model (2017)

International Journal of Nanomedicine 44 citations DOI OpenAlex